J. Wils

5.4k total citations · 1 hit paper
79 papers, 4.2k citations indexed

About

J. Wils is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, J. Wils has authored 79 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 24 papers in Surgery. Recurrent topics in J. Wils's work include Colorectal Cancer Treatments and Studies (43 papers), Gastric Cancer Management and Outcomes (32 papers) and Colorectal Cancer Surgical Treatments (15 papers). J. Wils is often cited by papers focused on Colorectal Cancer Treatments and Studies (43 papers), Gastric Cancer Management and Outcomes (32 papers) and Colorectal Cancer Surgical Treatments (15 papers). J. Wils collaborates with scholars based in Netherlands, Belgium and France. J. Wils's co-authors include Harry Bleiberg, Eric Van Cutsem, Roberto Labianca, Patrice Herait, Philippe Rougier, Lucile Awad, Kurt Possinger, Rudolf Morant, Emilio Bajetta and N. Niederle and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

J. Wils

77 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer

1998 786 citations Philippe Rougier, Eric Van Cutsem et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Wils Netherlands	30	2.9k	1.8k	1.2k	758	588	79	4.2k
Florin Sirzén Sweden	18	3.6k 1.2×	2.6k 1.4×	1.1k 0.9×	1.1k 1.4×	817 1.4×	28	5.5k
Jan Stoehlmacher Germany	26	3.4k 1.2×	1.8k 1.0×	1.1k 1.0×	785 1.0×	1.7k 2.9×	57	5.3k
P Rougier France	16	3.1k 1.1×	1.2k 0.6×	959 0.8×	1.2k 1.6×	617 1.0×	70	3.9k
M. Homerin France	10	2.9k 1.0×	883 0.5×	884 0.8×	944 1.2×	389 0.7×	17	3.5k
Bruce J. Giantonio United States	31	3.4k 1.2×	1.6k 0.9×	729 0.6×	959 1.3×	1.3k 2.2×	124	5.0k
Axel Grothey United States	29	2.6k 0.9×	1.4k 0.8×	685 0.6×	370 0.5×	896 1.5×	93	3.8k
Cynthia G. Leichman United States	30	4.6k 1.6×	2.0k 1.1×	1.7k 1.5×	611 0.8×	1.5k 2.5×	64	6.2k
Benoist Chibaudel France	28	2.9k 1.0×	1.3k 0.7×	1.0k 0.9×	510 0.7×	350 0.6×	157	3.7k
Lucile Awad France	9	4.1k 1.4×	1.5k 0.8×	1.0k 0.9×	1.4k 1.9×	1.1k 1.8×	10	4.8k
J. Załuski Poland	13	3.7k 1.3×	1.7k 0.9×	816 0.7×	855 1.1×	574 1.0×	23	4.5k

Countries citing papers authored by J. Wils

Since Specialization

Citations

This map shows the geographic impact of J. Wils's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Wils with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Wils more than expected).

Fields of papers citing papers by J. Wils

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Wils. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Wils. The network helps show where J. Wils may publish in the future.

Co-authorship network of co-authors of J. Wils

This figure shows the co-authorship network connecting the top 25 collaborators of J. Wils. A scholar is included among the top collaborators of J. Wils based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Wils. J. Wils is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lutz, Manfred P., H. Wilke, D. J. Theo Wagener, et al.. (2007). Weekly Infusional High-Dose Fluorouracil (HD-FU), HD-FU Plus Folinic Acid (HD-FU/FA), or HD-FU/FA Plus Biweekly Cisplatin in Advanced Gastric Cancer: Randomized Phase II Trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie. Journal of Clinical Oncology. 25(18). 2580–2585. 46 indexed citations

Köhne, Claus Henning, Eric Van Cutsem, J. Wils, et al.. (2005). Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. Journal of Clinical Oncology. 23(22). 4856–4865. 262 indexed citations

Folprecht, Gunnar, David Cunningham, Bengt Glimelius, et al.. (2004). Efficacy of bolus and infusional 5-FU in elderly and non-elderly patients with metastatic colorectal cancer - a pooled analysis of clinical trials. Journal of Clinical Oncology. 22(14_suppl). 8045–8045. 6 indexed citations

Labianca, Roberto, Giordano Beretta, Gemma Gatta, Filippo de Braud, & J. Wils. (2004). Colon cancer. Critical Reviews in Oncology/Hematology. 51(2). 145–170. 30 indexed citations

Folprecht, Gunnar, David Cunningham, Paul J. Ross, et al.. (2004). Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Annals of Oncology. 15(9). 1330–1338. 190 indexed citations

Wils, J.. (2001). Adjuvant therapy for colon cancer: the European experience.. PubMed. 87(1 Suppl 1). S85–S85. 2 indexed citations

Cutsem, Eric Van, M. Dicato, & J. Wils. (2001). Recent advances in the management of colorectal cancer. European Journal of Cancer. 37(18). 2302–2309. 8 indexed citations

Cutsem, Eric Van, David Cunningham, W.W. ten Bokkel Huinink, et al.. (1999). Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). European Journal of Cancer. 35(1). 54–59. 98 indexed citations

Rougier, Philippe, Eric Van Cutsem, Emilio Bajetta, et al.. (1998). Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. The Lancet. 352(9138). 1407–1412. 786 indexed citations breakdown →

10.

Nitti, Donato, J. Wils, Tarek Sahmoud, et al.. (1997). Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983–1987). European Journal of Cancer. 33(8). 1209–1215. 34 indexed citations

11.

Wils, J., et al.. (1997). Efficacy of carboplatin plus primary prophylactic filgrastim (granulocyte colony stimulating factor) in relapsed ovarian cancer. Anti-Cancer Drugs. 8(5). 432–435. 5 indexed citations

12.

Wils, J.. (1996). The treatment of advanced gastric cancer.. PubMed. 23(3). 397–406. 64 indexed citations

13.

Debets, J.M.H., et al.. (1995). The ‘pinch-off phenomenon’: a radiological symptom for potential fracture of an implanted permanent subclavian catheter system. European Journal of Radiology. 20(2). 112–113. 13 indexed citations

14.

Guastalla, Jean Paul, Jan B. Vermorken, J. Wils, et al.. (1994). Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy—a phase II study of the EORTC gynaecological cancer cooperative group. European Journal of Cancer. 30(1). 45–49. 15 indexed citations

15.

Wils, J., et al.. (1994). Gastric Cancer: Current status and future directions in the treatment of localized gastric cancer. Annals of Oncology. 5. S69–S72. 14 indexed citations

16.

Klein, H. O., Marc Buyse, & J. Wils. (1992). Prospective Randomized Trial Using 5-Fluorouracil, Adriamycin and Methotrexate (FAMTX) versus FAM for Treatment of Advanced Gastric Cancer. Oncology Research and Treatment. 15(5). 364–367. 5 indexed citations

17.

Wils, J.. (1992). Chemotherapy for Gastrointestinal Cancer: New Hopes or New Disappointments?. Scandinavian Journal of Gastroenterology. 27(sup194). 87–94. 3 indexed citations

18.

Wils, J., et al.. (1990). Phase II study of high-dose epirubicin in non-small cell lung cancer. European Journal of Cancer and Clinical Oncology. 26(11-12). 1140–1141. 33 indexed citations

19.

Bleiberg, Harry, Marc Buyse, P Haegèle, et al.. (1990). Randomized Phase II Study of a Combination of Cisplatin (DDP), 5-Fluorouracil (5-FU), and Allopurinol (HPP) Versus 5-FU in Advanced Colorectal Carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Cancer Investigation. 8(5). 471–475. 6 indexed citations

20.

Wils, J., et al.. (1989). Chemotherapy Consisting of Cisplatin, Doxorubicin, and Cyclophosphamide as an Adjunct to Surgery in Stage Ic-II Epithelial Ovarian Carcinoma. American Journal of Clinical Oncology. 12(3). 251–254. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact